Markel Group is set to report its latest quarterly earnings after the bell Wednesday. Investors will be watching to see if the insurer can build on last quarter's strong performance amid a challenging market for property and casualty stocks.
As Snap Inc. prepares to report its latest quarterly results, investors are watching closely for signs of sustained user growth and advertising resilience amid a turbulent market for tech stocks.
While many SaaS stocks are valued on revenue growth, Paycom Software presents a compelling, counterintuitive investment case. Its secret lies in a unique margin expansion engine powered by its Beti platform, which transforms customer maturity into sustained profitability and deepens client lock-in.
With prized Burmese teak off-limits due to sanctions and old-growth stocks dwindling, the luxury yacht industry is accelerating its search for viable—and sustainable—alternatives, from engineered woods to advanced synthetics.
The Trump administration unveiled plans for a strategic reserve of critical minerals, sparking a rally in domestic mining stocks and intensifying efforts to reduce reliance on China.
While many AI stocks trade at sky-high premiums, Nebius Group presents a contrasting case. Analysts project a staggering revenue surge for 2026, suggesting its current valuation might not fully reflect its growth trajectory in the competitive cloud AI space.
Amid a volatile market for mining stocks, Ramelius Resources stands out with a consistently high Return on Capital Employed (ROCE) of 30%, significantly outpacing its industry peers and fueling its multi-bagger potential.
While many AI stocks soared in 2025, Salesforce shares faced significant headwinds. Despite a challenging year, the cloud software giant's robust fundamentals and reasonable valuation suggest it may be poised for a recovery.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
U.S. stocks opened higher Monday, reversing earlier futures losses, as a stronger-than-expected manufacturing report boosted sentiment. The Dow Jones and Russell 2000 led the gains.
Despite OPEC+ maintaining production cuts, crude benchmarks fell sharply on Monday, pulling energy stocks like ConocoPhillips down with them as immediate fears of a supply disruption in the Persian Gulf subsided.
The Schwab U.S. Dividend Equity ETF (SCHD) offers investors a balanced approach to generating income, targeting financially robust companies with a history of growing dividends. We examine its strategy, performance, and role in a portfolio.
While investors flock to mass-market and electric vehicle stocks, Ferrari's unique strategy of cultivating scarcity and brand prestige has delivered enviable margins and pricing power. With shares well off their highs, analysts debate if now is the time to buy into this iconic automaker for the long haul.
First Pacific Advisors' FPA Crescent Fund disclosed it sold its position in tech giant Microsoft in Q4 2025. The value-focused fund explained the move was driven by a search for greater upside in other AI-related investments, despite acknowledging Microsoft's strong fundamentals.
While tech stocks dominate AI headlines, Welltower Inc. is leveraging artificial intelligence and demographic shifts to redefine senior living and create a powerful growth engine, positioning itself as a unique beneficiary of long-term healthcare trends.
U.S. stocks and precious metals fell sharply Monday as President Trump's surprise nomination of Kevin Warsh to lead the Federal Reserve injected fresh uncertainty into markets, reversing a recent dollar slump and cooling a historic gold rally.
The staggering cost of building AI infrastructure is pushing tech giants and startups alike into every corner of the debt market, from blue-chip bonds to private credit, reshaping investment portfolios and introducing new risks.
As warnings mount over loosening lending standards in the booming private credit market, investors are scrutinizing ultra-high-yield BDC stocks. While some show signs of stress, selective opportunities may still exist for those who look beyond the headline yield.
The UK pharmaceutical giant AstraZeneca begins trading ordinary shares on the New York Stock Exchange today, a significant upgrade from its previous Nasdaq ADR listing. This move underscores the company's strategic rebalancing towards the United States, its largest market, and raises questions about the long-term relevance of its London listing.
While the FTSE 100 grapples with global headwinds, a segment of smaller UK-listed companies presents distinct opportunities. We examine three firms, each with a market capitalisation over £90 million, that combine financial resilience with specific growth catalysts.
